NET PROFIT (x1000 DKK)
Novo Nordisk Region Europe A/S
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
242,136
|
0
|
225,085 |
| Total assets |
9,213,080
|
0
|
3,570,863 |
| Current assets |
798,966
|
0
|
274,237 |
| Current liabilities |
418,485
|
0
|
397,490 |
| Equity capital |
7,804,365
|
0
|
2,477,988 |
| - share capital |
108,371
|
0
|
108,371 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency | 84.7% | 69.4% | |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio | 190.9% | 69.0% | |
| Return on equity (ROE) | 3.1% | 9.1% | |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.